Cathay Biotech Inc - Asset Resilience Ratio

Latest as of September 2025: 3.85%

Cathay Biotech Inc (688065) has an Asset Resilience Ratio of 3.85% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Cathay Biotech Inc debt and liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥901.80 Million
≈ $131.96 Million USD Cash + Short-term Investments

Total Assets

CN¥23.45 Billion
≈ $3.43 Billion USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2019–2024)

This chart shows how Cathay Biotech Inc's Asset Resilience Ratio has changed over time. See Cathay Biotech Inc book value and equity for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Cathay Biotech Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Cathay Biotech Inc market cap and net worth.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥901.80 Million 3.85%
Total Liquid Assets CN¥901.80 Million 3.85%

Asset Resilience Insights

  • Limited Liquidity: Cathay Biotech Inc maintains only 3.85% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Cathay Biotech Inc Industry Peers by Asset Resilience Ratio

Compare Cathay Biotech Inc's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Zangge Holding Co Ltd
SHE:000408
Chemicals 0.32%
Shenzhen Chengxin Lithium Group Co Ltd
SHE:002240
Chemicals 0.26%
Suzhou Hesheng Special Material Co Ltd
SHE:002290
Chemicals 0.43%
Sichuan Chemical Co Ltd
SHE:000155
Chemicals 3.90%
Anhui Wanwei Updated High-tech Material Industry Co Ltd
SHG:600063
Chemicals 0.25%
Hubei Jianghan New Materials Co. Ltd. A
SHG:603281
Chemicals 5.29%
Robertet SA
PA:RBT
Chemicals 1.82%
Huafon Microfibre Shanghai Co
SHE:300180
Chemicals 0.02%

Annual Asset Resilience Ratio for Cathay Biotech Inc (2019–2024)

The table below shows the annual Asset Resilience Ratio data for Cathay Biotech Inc.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 0.00% CN¥469.25K
≈ $68.67K
CN¥19.02 Billion
≈ $2.78 Billion
0.00pp
2023-12-31 0.00% CN¥469.25K
≈ $68.67K
CN¥18.83 Billion
≈ $2.76 Billion
0.00pp
2022-12-31 0.00% CN¥469.25K
≈ $68.67K
CN¥17.83 Billion
≈ $2.61 Billion
0.00pp
2021-12-31 0.00% CN¥469.25K
≈ $68.67K
CN¥16.20 Billion
≈ $2.37 Billion
-10.96pp
2020-12-31 10.96% CN¥1.33 Billion
≈ $194.67 Million
CN¥12.14 Billion
≈ $1.78 Billion
-3.40pp
2019-12-31 14.36% CN¥859.22 Million
≈ $125.73 Million
CN¥5.98 Billion
≈ $875.32 Million
--
pp = percentage points

About Cathay Biotech Inc

SHG:688065 China Chemicals
Market Cap
$5.02 Billion
CN¥34.33 Billion CNY
Market Cap Rank
#3614 Global
#578 in China
Share Price
CN¥47.60
Change (1 day)
-0.56%
52-Week Range
CN¥45.43 - CN¥62.24
All Time High
CN¥134.07
About

Cathay Biotech Inc., together with its subsidiaries, engages in the research, development, production, and sale of bio-based materials in China and internationally. The company offers biological long-chain diacids, including sebacic acid and octadecanedioic acid; bio-based polyamides; and bio-based pentamethylene diamine under the TERRYL and ECOPENT brands. It also provides digital solutions for … Read more